EQS-Adhoc: RELIEF THERAPEUTICS Holding AG: Relief Reports US Collaboration Partner Announces Expansion of Aviptadil US Expanded Access & Right to Try Programs for Patients w/COVID-19 Respiratory Failure who've Exhausted All Approved Therapies
EQS-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Miscellaneous Relief Reports US Collaboration Partner Announces Expansion of Aviptadil US Expanded Access & Right to Try Programs for Patients
Michael Miller Jack Weinstein Jonathan Javitt Advita Lifescience Gmb Pharma Research Drug Administration
Source: finanznachrichten.de